Latest Leadership News

Raiz Invest posted a 21% revenue jump and a 93% surge in underlying EBITDA for FY26, marking a return to profitability amid a CEO transition and a strategic shift towards a broader wealth platform.

Credit Clear Limited posted a 28% rise in FY26 revenue to $60 million, boosted by UK acquisitions and organic growth, while defending legal action by the ACCC.

Aerometrex delivered a landmark FY26 with operating revenue up 12.3% to $26.84 million and EBITDA more than doubling to $7.68 million, driven by a 27.2% jump in MetroMap subscription revenue and a 37.8% rise in Annual Contract Value.

Solution Dynamics Limited reported an 85% drop in net profit for FY2026 to NZD 0.38 million, hit by a major contract loss and investment in its new AI-driven dental marketing platform, nGAGE.

Summerset Group Holdings posted a 92% jump in half-year net profit to NZ$171.4 million, driven by strong sales and disciplined cash management. The company also updated its dividend policy to align payouts with operating cash flow, reflecting its maturing portfolio and cautious growth approach.

Corporate Travel Management has arranged a $175 million debt facility with Pacific Equity Partners Credit, replacing its $75 million corporate facility to support UK client remediation and ongoing operations ahead of FY25 and 1H26 financial statements.

Alliance Aviation Services posted a statutory loss of $90.9 million in FY2026, driven by a $164.8 million impairment on its Fokker fleet, while underlying profit remained within guidance. The company is realigning around core FIFO operations, fleet renewal, and cost discipline, supported by a $40 million equity raise and revised Qantas wet lease terms.

Ora Banda Mining delivered record FY26 results with a 53% jump in gold production and doubled revenue to $807.5 million, underpinning its DRIVE to 300 growth strategy targeting 300,000 ounces annually by FY29.

Imagion Biosystems has signed key CRO work orders and completed manufacturing of its MagSense HER2 Imaging Agent, advancing its Phase 1b/2 clinical trial targeting HER2+ breast cancer. Trial initiation is underway with seven prospective sites, including contract talks with the first US clinical site.

Lynas Rare Earths delivered a record A$977.9 million revenue and A$222.4 million net profit in FY26, underpinned by strong rare earth production, strategic supply agreements, and a 10-year Malaysian licence renewal.

L1 Long Short Fund Limited (ASX:LSF) posted a standout FY26 with a 45.4% net portfolio return, driving a 538% jump in net profit after tax to $635 million and a 22% CAGR in dividends since IPO. The fund also released its inaugural climate-related disclosures, affirming resilience amid evolving risks.

Urbanise.com Limited reported 14.3% revenue growth to $15 million in FY2026, significantly narrowing its net loss to $0.9 million while advancing a NAB partnership pilot and launching AI features.